Literature DB >> 15355868

Phenotypes in asthma: useful guides for therapy, distinct biological processes, or both?

Sally E Wenzel.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15355868     DOI： 10.1164/rccm.2407005

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  10 in total

1.  Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma.

Authors:  Raed A Dweik; Ronald L Sorkness; Sally Wenzel; Jeffrey Hammel; Douglas Curran-Everett; Suzy A A Comhair; Eugene Bleecker; William Busse; William J Calhoun; Mario Castro; Kian Fan Chung; Elliot Israel; Nizar Jarjour; Wendy Moore; Stephen Peters; Gerald Teague; Benjamin Gaston; Serpil C Erzurum
Journal:  Am J Respir Crit Care Med       Date:  2010-02-04       Impact factor: 21.405

2.  An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications.

Authors:  Raed A Dweik; Peter B Boggs; Serpil C Erzurum; Charles G Irvin; Margaret W Leigh; Jon O Lundberg; Anna-Carin Olin; Alan L Plummer; D Robin Taylor
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

3.  Clinical asthma phenotyping: A trial for bridging gaps in asthma management.

Authors:  Magdy Mohamed Zedan; Wafaa Nabil Laimon; Amal Mohamed Osman; Mohamed Magdy Zedan
Journal:  World J Clin Pediatr       Date:  2015-05-08

4.  Applied breath analysis: an overview of the challenges and opportunities in developing and testing sensor technology for human health monitoring in aerospace and clinical applications.

Authors:  Gary W Hunter; Raed A Dweik
Journal:  J Breath Res       Date:  2008-09       Impact factor: 3.262

5.  TFR1 expression in induced sputum is associated with asthma severity.

Authors:  Yang Wang; Li Feng Gu; Xincheng Zhao; Chengping Hu; Qiong Chen
Journal:  PeerJ       Date:  2022-05-17       Impact factor: 3.061

Review 6.  Understanding the mechanisms of viral induced asthma: new therapeutic directions.

Authors:  Nicole G Hansbro; Jay C Horvat; Peter A Wark; Philip M Hansbro
Journal:  Pharmacol Ther       Date:  2008-01-29       Impact factor: 12.310

7.  The chitinase-like protein YKL-40 modulates cystic fibrosis lung disease.

Authors:  Andreas Hector; Michael S D Kormann; Ines Mack; Philipp Latzin; Carmen Casaulta; Elisabeth Kieninger; Zhe Zhou; Ali Ö Yildirim; Alexander Bohla; Nikolaus Rieber; Matthias Kappler; Barbara Koller; Ernst Eber; Olaf Eickmeier; Stefan Zielen; Oliver Eickelberg; Matthias Griese; Marcus A Mall; Dominik Hartl
Journal:  PLoS One       Date:  2011-09-20       Impact factor: 3.240

8.  IgE mediated sensitisation to aeroallergens in an asthmatic cohort: relationship with inflammatory phenotypes and disease severity.

Authors:  M Manise; B Bakayoko; F Schleich; J-L Corhay; R Louis
Journal:  Int J Clin Pract       Date:  2016-06-28       Impact factor: 2.503

Review 9.  Identifying and hurdling obstacles to translational research.

Authors:  Ian Sabroe; David H Dockrell; Stefanie N Vogel; Stephen A Renshaw; Moira K B Whyte; Steven K Dower
Journal:  Nat Rev Immunol       Date:  2007-01       Impact factor: 53.106

10.  Sputum analysis in diagnosis and management of obstructive airway diseases.

Authors:  Paige Lacy; Jennifer L Lee; Dilini Vethanayagam
Journal:  Ther Clin Risk Manag       Date:  2005-09       Impact factor: 2.423
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.